Abstract
Posttraumatic stress disorder (PTSD) is a syndrome that affects a substantial portion of both the civilian and military populations, and is often underdiagnosed due to complications with delayed onset and co-occurring psychiatric disorders. The prevalence of this devastating disorder is growing as more people come forward with traumatic events in their past. It is crucial that we develop a more comprehensive diagnostic and therapeutic framework for PTSD in order to reduce harm and aid in long-term functional recovery. Currently accepted therapeutic options for PTSD are proving to be insufficient as increasing numbers of people present with treatment-resistant PTSD, and alternative avenues for diagnosis and treatment are currently being investigated to improve standards of patient care. This chapter focuses on the rationale for why ayahuasca may be successful in treating certain kinds of PTSD, and reviews the previously reported pathophysiology of PTSD and its current treatments, and the new, experimental therapies being explored. This chapter also proposes a novel method known as “syndromics ,” which aims to characterize the full syndrome of PTSD using bioinformatics and multivariate pattern detection, in the hopes that by understanding the full complexity of this syndrome, we will be able to identify more efficient therapeutic targets, such as ayahuasca, to cure it.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
American Psychological Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, D.C.: Author.
Barker, S. A., McIlhenny, E. H., & Strassman, R. (2012). A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955–2010. Drug Testing and Analysis, 4(7–8), 617–635. doi:10.1002/dta.422.
Blaustein, M., Cook, A., Cloitre, M., DeRosa, R., Ford, J., Henderson, M., et al. (2003). Complex trauma in children and adolescents: White paper from the National Child Traumatic Stress Network Complex Trauma Task Force. Retrieved June 18, 2013 from from http://www.nctsn.org/sites/default/files/assets/pdfs/ComplexTrauma_All.pdf.
Bouso, J. C., Doblin, R., Farre, M., Alcazar, M. A., & Gomez-Jarabo, G. (2008). MDMA-assisted psychotherapy using low doses in a small sample of women with chronic post-traumatic stress disorder. Journal of Psychoactive Drugs, 40(3), 225–236.
Brewin, C. R., Andrews, B., & Valentine, J. D. (2000). Meta-analysis of risk factors for post-traumatic stress disorder in trauma-exposed adults. Journal of Consulting and Clinical Psychology, 68(5), 748–766.
Callaway, J. C., Airaksinen, M. M., McKenna, D. J., Brito, G. S., & Grob, C. S. (1994). Platelet serotonin uptake sites increased in drinkers of ayahuasca. Psychopharmacology (Berl), 116(3), 385–387.
Caudle, K. L., Brown, E. H., Shum-Siu, A., Burke, D. A., Magnuson, T. S., Voor, M. J., et al. (2011). Hindlimb immobilization in a wheelchair alters functional recovery following contusive spinal cord injury in the adult rat. Neurorehabil Neural Repair, 25(8), 729–739. doi:10.1177/1545968311407519.
Dao, J., & Lehren, A. W. (2013, May 15). Baffling rise in suicides plagues the U.S. military. New York Times. Retrieved from http://www.nytimes.com/2013/05/16/us/baffling-rise-in-suicides-plagues-us-military.html.
de Araujo, D. B., Ribeiro, S., Cecchi, G. A., Carvalho, F. M., Sanchez, T. A., Pinto, J. P., et al. (2012). Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestion. Human Brain Mapping, 33(11), 2550−2560. doi: 10.1002/hbm.21381.
Dharmshaktu, P., Tayal, V., & Kalra, B. S. (2012). Efficacy of antidepressants as analgesics: A review. Journal of Clinical Pharmacology, 52(1), 6–17. doi:10.1177/0091270010394852.
Dolan, E. W. (2011, May 16). Federal agency blocks FDA-approved marijuana research for veterans. Retrieved June 18, 2013 from http://www.rawstory.com/rs/2011/10/04/dept-of-health-and-human-services-blocks-fda-approved-marijuana-research-for-veterans/.
Dos Santos, R. G., Valle, M., Bouso, J. C., Nomdedeu, J. F., Rodriguez-Espinosa, J., McIlhenny, E. H., et al. (2011). Autonomic, neuroendocrine, and immunological effects of ayahuasca: A comparative study with d-amphetamine. Journal of Clinical Psychopharmacology, 31(6), 717–726. doi: 10.1097/JCP.0b013e31823607f6.
Drug Enforcement Administration. (2011). Drugs of abuse. Retrieved June 18, 2013 from http://www.justice.gov/dea/docs/drugs_of_abuse_2011.pdf.
Engel, G. L. (1977). The need for a new medical model: A challenge for biomedicine. Science, 196(4286), 129–136.
Erowid. (2012). Ayahuasca reports. Retrieved June 18, 2013 from http://www.erowid.org/experiences/subs/exp_Ayahuasca.shtml.
Erowid. (2013, 4/25/13). Ayahuasca fatalities/deaths. Retrieved June 18, 2013 from http://www.erowid.org/chemicals/ayahuasca/ayahuasca_death.shtml.
Feinberg, J. (2013). Wordle. Retrieved May 20, 2013 from http://www.wordle.net/.
Ferguson, A. R., Huie, J. R., Crown, E. D., Baumbauer, K. M., Hook, M. A., Garraway, S. M. et al. (2012a). Maladaptive spinal plasticity opposes spinal learning and recovery in spinal cord injury. Frontiers in Physiology, 3, 399. doi: 10.3389/fphys.2012.00399.
Ferguson, A. R., Huie, J. R., Crown, E. D., & Grau, J. W. (2012b). Central nociceptive sensitization vs. spinal cord training: Opposing forms of plasticity that dictate function after complete spinal cord injury. Frontiers in Physiology, 3, 396. doi: 10.3389/fphys.2012.00396.
Ferguson, A. R., Irvine, K. A., Gensel, J. C., Nielson, J. L., Lin, A., Ly, J., et al. (2013). Derivation of multivariate syndromic outcome metrics for consistent testing across multiple models of cervical spinal cord injury in rats. PLoS One, 8(3), e59712. doi: 10.1371/journal.pone.0059712.
Ferguson, A. R., Stuck, E. D., & Nielson, J. L. (2011). Syndromics: A bioinformatics approach for neurotrauma research. Translational Stroke Research, 2(4), 438–454.
Gould, M., Greenberg, N., & Hetherton, J. (2007). Stigma and the military: Evaluation of a PTSD psychoeducational program. Journal of Traumatic Stress, 20(4), 505–515. doi:10.1002/jts.20233.
Grau, J. W., Huie, J. R., Garraway, S. M., Hook, M. A., Crown, E. D., Baumbauer, K. M., et al. (2012). Impact of behavioral control on the processing of nociceptive stimulation. Frontiers in Physiology, 3, 262. doi: 10.3389/fphys.2012.00262.
Grau, J. W., Hyson, R. L., Maier, S. F., Madden, J. T., & Barchas, J. D. (1981). Long-term stress-induced analgesia and activation of the opiate system. Science, 213(4514), 1409–1411.
Hains, B. C., Everhart, A. W., Fullwood, S. D., & Hulsebosch, C. E. (2002). Changes in serotonin, serotonin transporter expression, and serotonin denervation supersensitivity: Involvement in chronic central pain after spinal hemisection in the rat. Experimental Neurology, 175(2), 347–362. doi:10.1006/exnr.2002.7892.
Johnson, S. L. (2009). Therapist’s guide to posttraumatic stress disorder intervention (1st ed.). London: Academic Press.
Jones, T., & Moller, M. D. (2011). Implications of hypothalamic-pituitary-adrenal axis functioning in posttraumatic stress disorder. Journal of the American Psychiatric Nurses Association, 17(6), 393–403. doi:10.1177/1078390311420564.
Kaloupek, D. G., Chard, K. M., Freed, M. C., Peterson, A. L., Riggs, D. S., Stein, M. B., et al. (2010). Common data elements for posttraumatic stress disorder research. Archives of Physical Medicine and Rehabilitation, 91(11), 1684–1691. doi:10.1016/j.apmr.2010.06.032.
Leary, T. (1966). Programmed communication during experiences with DMT. Psychedelic Review, 8, 83–95.
Ledford, H. (2013). Psychiatry framework seeks to reform diagnostic doctrine. Advance online publication. Nature. doi: 10.1038/nature.2013.12972.
Levine, P. A., & Frederick, A. (1997). Waking the tiger: Healing trauma. Berkeley, CA: North Atlantic Books.
Lewis, T., Amini, F., & Lannon, R. (2000). A general theory of love. New York, NY: Vintage Books.
Longo, L. P., & Johnson, B. (2000). Addiction: Part I. Benzodiazepines—side effects, abuse risk, and alternatives. American Family Physician, 61(7), 2121–2128.
Longo, L. P., Parran, T, Jr, Johnson, B., & Kinsey, W. (2000). Addiction: Part II. Identification and management of the drug-seeking patient. American Family Physician, 61(8), 2401–2408.
Lyalka, V. F., Hsu, L. J., Karayannidou, A., Zelenin, P. V., Orlovsky, G. N., & Deliagina, T. G. (2011). Facilitation of postural limb reflexes in spinal rabbits by serotonergic agonist administration, epidural electrical stimulation, and postural training. Journal of Neurophysiology, 106(3), 1341–1354. doi:10.1152/jn.00115.2011.
McKay, K. M., Imel, Z. E., & Wampold, B. E. (2006). Psychiatrist effects in the psychopharmacological treatment of depression. Journal of Affective Disorders, 92(2–3), 287–290. doi:10.1016/j.jad.2006.01.020.
McKenna, D. J. (2004). Clinical investigations of the therapeutic potential of ayahuasca: Rationale and regulatory challenges. Pharmacology & Therapeutics, 102(2), 111–129. doi:10.1016/j.pharmthera.2004.03.002.
Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R. (2011). The safety and efficacy of {±}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant post-traumatic stress disorder: The first randomized controlled pilot study. Journal of Psychopharmacology, 25(4), 439–452. doi:10.1177/0269881110378371.
Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., Martin, S. F., Yazar-Klosinski, B., et al. (2013). Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: A prospective long-term follow-up study. Journal of Psychopharmacology, 27(1), 28−39. doi: 10.1177/0269881112456611.
Multidisciplinary Association for Psychedelic Studies. (2013). MDMA-assisted psychotherapy. Research. Retrieved May 18, 2013 from http://www.maps.org/research/mdma/.
Murphy, S. E. (2010). Using functional neuroimaging to investigate the mechanisms of action of selective serotonin reuptake inhibitors (SSRIs). Current Pharmaceutical Design, 16(18), 1990–1997.
Murrough, J. W., Huang, Y., Hu, J., Henry, S., Williams, W., Gallezot, J. D., et al. (2011). Reduced amygdala serotonin transporter binding in post-traumatic stress disorder. Biological Psychiatry, 70(11), 1033−1038. doi: 10.1016/j.biopsych.2011.07.003.
National Institute of Mental Health. (2011). Research Domain Criteria (RDoC). Retrieved June 18, 2013 from http://www.nimh.nih.gov/research-funding/rdoc/nimh-research-domain-criteria-rdoc.shtml#toc_product.
Neumeister, A., Normandin, M. D., Pietrzak, R. H., Piomelli, D., Zheng, M. Q., Gujarro-Anton, A. (2013). Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: A positron emission tomography study. Advance online publication. Molecular Psychiatry. doi: 10.1038/mp.2013.61.
Oehen, P., Traber, R., Widmer, V., & Schnyder, U. (2013). A randomized, controlled pilot study of MDMA (+/− 3,4-Methylenedioxymethamphetamine)-Assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). Journal of Psychopharmacology, 27(1), 40–52. doi:10.1177/0269881112464827.
Petty, F., Kramer, G., & Wilson, L. (1992). Prevention of learned helplessness: In vivo correlation with cortical serotonin. Pharmacology, Biochemistry and Behavior, 43(2), 361–367.
Prigerson, H. G., Maciejewski, P. K., & Rosenheck, R. A. (2002). Population attributable fractions of psychiatric disorders and behavioral outcomes associated with combat exposure among US men. American Journal of Public Health, 92(1), 59–63.
Riba, J., Rodriguez-Fornells, A., & Barbanoj, M. J. (2002). Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively. Psychopharmacology (Berl), 165(1), 18–28. doi:10.1007/s00213-002-1237-5.
Riba, J., Romero, S., Grasa, E., Mena, E., Carrio, I., & Barbanoj, M. J. (2006). Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant. Psychopharmacology (Berl), 186(1), 93–98. doi:10.1007/s00213-006-0358-7.
Saladin, M. E., Brady, K. T., Dansky, B. S., & Kilpatrick, D. G. (1995). Understanding comorbidity between PTSD and substance use disorders: Two preliminary investigations. Addictive Behaviors, 20(5), 643–655.
Shepherd, J. D., & Bear, M. F. (2011). New views of Arc, a master regulator of synaptic plasticity. Nature Neuroscience, 14(3), 279–284. doi:10.1038/nn.2708.
Stein, M. B., McQuaid, J. R., Pedrelli, P., Lenox, R., & McCahill, M. E. (2000). Post-traumatic stress disorder in the primary care medical setting. General Hospital Psychiatry, 22(4), 261.
Stickgold, R. (2002). EMDR: A putative neurobiological mechanism of action. Journal of Clinical Psychology, 58(1), 61–75.
Terr, L. (1990). Too scared to cry: How trauma affects children and ultimately us all. New York, NY: Basic Books.
Thomas, G., Lucas, P., Capler, N. R., Tupper, K. W., & Martin, G. (2013). Ayahuasca-assisted therapy for addiction: Results from a preliminary observational study in Canada. Advance online publication. Current Drug Abuse Reviews. 6(1):30–42
United States, & United States Drug Enforcement Administration, Office of Chief Counsel. (1996). Controlled Substances Act as amended to February 15, 1996. Washington, D. C.: U.S. Dept. of Justice, Drug Enforcement Administration, Office of Chief Counsel.
Ursano, R. J., Bell, C., Eth, S., Friedman, M., Norwood, A., Pfefferbaum, B. (2004). Practice guideline for the treatment of patients with acute stress disorder and post-traumatic stress disorder. American Journal of Psychiatry, 161(11 Suppl), 3−31.
van der Kolk, B., Greenberg, M., Boyd, H., & Krystal, J. (1985). Inescapable shock, neurotransmitters, and addiction to trauma: Toward a psychobiology of post-traumatic stress. Biological Psychiatry, 20(3), 314–325.
Wang, D., & Sun, T. (2011). Neural plasticity and functional recovery of human central nervous system with special reference to spinal cord injury. Spinal Cord, 49(4), 486–492. doi:10.1038/sc.2010.124.
Yehuda, R. (2002). Post-traumatic stress disorder. New England Journal of Medicine, 346(2), 108–114. doi:10.1056/NEJMra012941.
Zimmerman, M., & Mattia, J. I. (1999). Is post-traumatic stress disorder underdiagnosed in routine clinical settings? The Journal of Nervous and Mental Disease, 187(7), 420–428.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Nielson, J.L., Megler, J.D. (2014). Ayahuasca as a Candidate Therapy for PTSD. In: Labate, B.C., Cavnar, C. (eds) The Therapeutic Use of Ayahuasca. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40426-9_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-40426-9_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-40425-2
Online ISBN: 978-3-642-40426-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)